News

9th May 2024

Jonathan Berlent Joins Merakris as SVP, Head of Strategy and Operations

12th March 2024

Favorable Results From Dermacyte® Matrix Research Study Published in March Issue of Journal of Wound Care

20th February 2024

Merakris Therapeutics to Release Final Part 1 Data From Phase 2 Multicenter Investigational Drug Study for Dermacyte® Liquid

5th December 2023

Merakris To Share Data from Fully Enrolled First Part of Two-Part Dermacyte® Liquid Clinical Trial

12th October 2023

Merakris Announces Nationwide At-Your-Door Autologous Serum Tears Program

1 2

Top